RESUMEN
BACKGROUND: This study investigated the frequency of diabetic gastroparesis and associated risk factors in a real-world clinical setting. METHODS: This retrospective cross-sectional study included patients who underwent assessments of solid gastric emptying time (GET) by technetium-99 m scintigraphy between May 2019 and December 2020. We categorized patients into three groups according to gastric retention of technetium-99 m: rapid (< 65% at 1 h or < 20% at 2 h), normal (≤60% at 2 h and/or ≤ 10% at 4 h), and delayed (> 60% at 2 h and/or > 10% at 4 h). RESULTS: Patients with diabetes mellitus (DM) were more likely to show abnormal GET than those without DM (119 [70.8%] vs. 16 [44.4%]). The mean glycated A1c was 10.3% in DM patients. DM patients with normal GET were significantly younger (57.2 years, P = 0.044) than those with delayed (65.0 years) or rapid GET (60.2 years). Fasting glucose levels were the lowest in the normal GET group and the highest in the rapid GET group (delayed: 176.3 mg/dL, normal: 151.2 mg/dL, rapid: 181.0 mg/dL, P = 0.030). However, glycated A1c was not significantly different among the delayed, normal, and rapid GET groups in patients with DM. Patients with delayed and rapid GET showed a higher frequency of retinopathy (6.0 vs. 15.5%, P = 0.001) and peripheral neuropathy (11.3 vs. 24.4%, P = 0.001) than those with normal GET. In the multinomial logistic regression analysis, retinopathy demonstrated a positive association with delayed GET, while nephropathy showed a significant negative correlation. CONCLUSION: DM gastroparesis in the clinical setting was not uncommon. Abnormal GET, including delayed and rapid GET, was associated with DM retinopathy or peripheral neuropathy.
Asunto(s)
Diabetes Mellitus , Neuropatías Diabéticas , Gastroparesia , Enfermedades de la Retina , Tecnecio , Humanos , Gastroparesia/epidemiología , Gastroparesia/etiología , Vaciamiento Gástrico , Estudios de Cohortes , Estudios Retrospectivos , Estudios Transversales , Neuropatías Diabéticas/epidemiología , Neuropatías Diabéticas/complicaciones , Enfermedades de la Retina/complicaciones , Diabetes Mellitus/epidemiologíaRESUMEN
Gastroparesis is a gastrointestinal disorder characterized by significant prolongation of gastric emptying time caused by impaired motility of the stomach. Its estimated prevalence is 24.2 per 100 000 people. However, the prevalence of gastroparesis in Asian countries is unknown due to a limited number of epidemiological studies and significant phenotypic variability of the Asian population in these studies. Analysis of previous research on gastroparesis and functional bowel disorders reveals the possibility of an increased prevalence among Asian individuals. A comparison of ethnic constituents between the recent United Kingdom gastroparesis study and its mother database has demonstrated a higher prevalence of gastroparesis among British Asian patients when compared with British Caucasian patients. An estimated gastroparesis prevalence in the Asian population can be calculated by identifying the individuals who are likely to demonstrate a delayed gastric emptying from all diagnosed functional dyspepsia patients. We suggest that gastroparesis tends to be underdiagnosed in Asians due to a lack of studies on gastroparesis in the Asian continent, a lack of knowledge among practitioners, and poor availability of scintigraphy testing as well as limited therapeutic options for this disease. Given the high probability of Asian predominance in gastroparesis and its disease impact on quality of life, epidemiological research focusing on the Asian population is required.
Asunto(s)
Gastroparesia , Humanos , Gastroparesia/epidemiología , Gastroparesia/etiología , Calidad de Vida , Prevalencia , Costo de Enfermedad , Asia/epidemiología , Vaciamiento GástricoRESUMEN
BACKGROUND: Delayed gastric emptying (DGE) commonly occurs after pancreaticoduodenectomy (PD). Risk factors for DGE have been reported in open PD but are rarely reported in laparoscopic PD (LPD). This study was designed to evaluate the perioperative risk factors for DGE and secondary DGE after LPD in a single center. METHODS: This retrospective cohort study included patients who underwent LPD between October 2014 and April 2023. Demographic data, preoperative, intraoperative, and postoperative data were collected. The risk factors for DGE and secondary DGE were analyzed. RESULTS: A total of 827 consecutive patients underwent LPD. One hundred and forty-two patients (17.2%) developed DGE of any type. Sixty-five patients (7.9%) had type A, 62 (7.5%) had type B, and the remaining 15 (1.8%) had type C DGE. Preoperative biliary drainage (p = 0.032), blood loss (p = 0.014), and 90-day any major complication with Dindo-Clavien score ≥ III (p < 0.001) were independent significant risk factors for DGE. Seventy-six (53.5%) patients were diagnosed with primary DGE, whereas 66 (46.5%) patients had DGE secondary to concomitant complications. Higher body mass index, soft pancreatic texture, and perioperative transfusion were independent risk factors for secondary DGE. Hospital stay and drainage tube removal time were significantly longer in the DGE and secondary DGE groups. CONCLUSION: Identifying patients at an increased risk of DGE and secondary DGE can be used to intervene earlier, avoid potential risk factors, and make more informed clinical decisions to shorten the duration of perioperative management.
Asunto(s)
Vaciamiento Gástrico , Laparoscopía , Pancreaticoduodenectomía , Complicaciones Posoperatorias , Humanos , Pancreaticoduodenectomía/efectos adversos , Masculino , Femenino , Estudios Retrospectivos , Laparoscopía/efectos adversos , Laparoscopía/métodos , Persona de Mediana Edad , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Anciano , Factores de Riesgo , Vaciamiento Gástrico/fisiología , Gastroparesia/etiología , Gastroparesia/epidemiología , AdultoRESUMEN
BACKGROUND: Dyspepsia is a prevalent condition in the general population. Besides organic causes, the differential diagnosis of dyspepsia includes functional dyspepsia (FD) and gastroparesis (GP) which share similar pathophysiological mechanisms and clinical presentation. So far, no study investigated the prevalence of FD and GP in a primary care in Belgium. METHODS: Data were obtained from Intego, a Flemish-Belgian general practice-based morbidity registration network. From 586,164 patients between 2000 and 2021, we selected patients with ICD-10 code for FD and GP. Patients with organic gastrointestinal diseases were excluded. We determined demographics and comorbidities of FD/GP. For prevalence and incidence calculation, we included those who consulted their general practitioners at least once in the given year. Pair-wise comparison was conducted to access the impact of comorbidities on risk of FD/GP. KEY RESULTS: Between 2011 and 2021, the prevalence of FD/GP ranged from 1.03% to 1.21%. The incidence of FD/GP ranged from 109 to 142 per 100,000 adults. In total 5242 cases of FD/GP were identified. These cases shared commonly coexisting diagnoses of gastroesophageal reflux disease (18.8%), irritable bowel syndrome (17.1%), and chronic constipation (18.7%). Patients with somatization/anxiety/depression had significantly higher risk of FD/GP, compared to the control (OR 1.38, 95% CI 1.19-1.61, p < 0.01). CONCLUSIONS AND INFERENCES: The prevalence (1.03%-1.21%) and incidence (109-142/100,000) of FD/GP in primary care over last decade appear to conflict with epidemiological research in the general population. The discrepancies suggest a potential lack of awareness of FD and GP among physicians and/or patients in Flemish-Belgium.
Asunto(s)
Dispepsia , Gastroparesia , Atención Primaria de Salud , Sistema de Registros , Humanos , Dispepsia/epidemiología , Dispepsia/diagnóstico , Bélgica/epidemiología , Gastroparesia/epidemiología , Gastroparesia/diagnóstico , Gastroparesia/fisiopatología , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Prevalencia , Bases de Datos Factuales , Adulto Joven , Adolescente , IncidenciaRESUMEN
BACKGROUND: Avoidant/restrictive food intake disorder (ARFID) prevalence in children with gastroparesis (Gp) and/or functional dyspepsia (FD) is unknown. We aimed to identify ARFID prevalence and trajectory over 2 months in children with Gp, FD, and healthy children (HC) using two screening questionnaires. We also explored the frequency of a positive ARFID screen between those with/without delayed gastric emptying or abnormal fundic accommodation. METHODS: In this prospective longitudinal study conducted at an urban tertiary care hospital, patients ages 10-17 years with Gp or FD and age- and gender-matched HC completed two validated ARFID screening tools at baseline and 2-month follow-up: the Nine Item ARFID Screen (NIAS) and the Pica, ARFID, and Rumination Disorder Interview-ARFID Questionnaire (PARDI-AR-Q). Gastric retention and fundic accommodation (for Gp and FD) were determined from gastric emptying scintigraphy. KEY RESULTS: At baseline, the proportion of children screening positive for ARFID on the NIAS versus PARDI-AR-Q was Gp: 48.5% versus 63.6%, FD: 66.7% versus 65.2%, HC: 15.3% versus 9.7%, respectively; p < 0.0001 across groups. Of children who screened positive at baseline and participated in the follow-up, 71.9% and 53.3% were positive 2 months later (NIAS versus PARDI-AR-Q, respectively). A positive ARFID screen in Gp or FD was not related to the presence/absence of delayed gastric retention or abnormal fundic accommodation. CONCLUSIONS & INFERENCES: ARFID detected from screening questionnaires is highly prevalent among children with Gp and FD and persists for at least 2 months in a substantial proportion of children. Children with these disorders should be screened for ARFID.
Asunto(s)
Trastorno de la Ingesta Alimentaria Evitativa/Restrictiva , Dispepsia , Gastroparesia , Humanos , Dispepsia/epidemiología , Niño , Gastroparesia/epidemiología , Gastroparesia/diagnóstico , Gastroparesia/fisiopatología , Femenino , Masculino , Adolescente , Prevalencia , Estudios Prospectivos , Estudios Longitudinales , Vaciamiento Gástrico/fisiología , Encuestas y CuestionariosRESUMEN
OBJECTIVE: To determine the prevalence and associations between anxiety/depression, and gastrointestinal (GI) symptoms across gastroparesis and functional dyspepsia. METHODS: Twenty adult studies were identified through systematic searches of three databases (PubMed, CINAHL and PsycINFO) in September 2023. Meta-analysis was performed to estimate the pooled prevalence rates of anxiety and depression across gastroparesis and functional dyspepsia, and to determine whether the associations of anxiety/depression and gastrointestinal (GI) symptoms differ in gastroparesis versus functional dyspepsia. RESULTS: The overall pooled prevalence rate for anxiety was similar (χ2(1) = 2.45, p = .12) in gastroparesis (49%) and functional dyspepsia (29%). The overall pooled prevalence rate for depression in gastroparesis (39%), and functional dyspepsia (32%) was also similar (χ2(1) = 0.81, p = .37). No significant relationship between anxiety and GI symptoms (r = 0.11) or depression and GI symptoms (r = 0.16) was found in gastroparesis, whilst significant, though weak, positive relationships between anxiety and GI symptoms (r = 0.30) and depression and GI symptoms (r = 0.32) were found in functional dyspepsia. The association between GI symptoms and anxiety, but not depression, across gastroparesis and functional dyspepsia was found to be significant (χ2(1) = 5.22, p = .02). CONCLUSION: Contributing to ongoing debate as to whether gastroparesis and functional dyspepsia are interchangeable syndromes, this review found that anxiety and depression prevalence was similar in both conditions. Psychological assessment and the utilisation of effective and holistic care in both conditions is therefore warranted.
Asunto(s)
Ansiedad , Depresión , Dispepsia , Gastroparesia , Humanos , Gastroparesia/epidemiología , Gastroparesia/psicología , Dispepsia/epidemiología , Dispepsia/psicología , Prevalencia , Depresión/epidemiología , Ansiedad/epidemiología , Enfermedades Gastrointestinales/epidemiología , Enfermedades Gastrointestinales/psicologíaRESUMEN
BACKGROUND: Delayed gastric emptying (DGE) is a frequent complication after pancreatoduodenectomy. Preoperative factors are limited and controversial. This study aims to identify associated factors related to this complication in the Colombian population. METHODS: A retrospective review of a prospectively collected database was conducted. All patients over 18 years of age who underwent pancreaticoduodenectomy were included. Associations with DGE syndrome were evaluated with logistic regression analysis, Odds ratio, and b-coefficient were provided when appropriate. RESULTS: 205 patients were included. Male patients constituted 54.15% (n = 111). 53 patients (25.85%) were diagnosed with DGE syndrome. Smoking habit (OR 17.58 p 0.00 95% CI 7.62-40.51), hydromorphone use > 0.6 mg/daily (OR 11.04 p 0.03 95% CI 1.26-96.66), bilirubin levels > 6 mg/dL (OR 2.51 p 0.02 95% CI 1.12-5.61), and pancreatic fistula type B (OR 2.72 p 0.02 CI 1.74-10.00). DISCUSSION: Smoking history, opioid use (hydromorphone > 0.6 mg/Daily), type B pancreatic fistula, and bilirubin levels > 6 mg/dL should be considered as risk factors for DGE.
Asunto(s)
Vaciamiento Gástrico , Pancreaticoduodenectomía , Complicaciones Posoperatorias , Humanos , Pancreaticoduodenectomía/efectos adversos , Masculino , Factores de Riesgo , Estudios Retrospectivos , Femenino , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Persona de Mediana Edad , Vaciamiento Gástrico/fisiología , Anciano , Gastroparesia/etiología , Gastroparesia/epidemiología , Fumar/efectos adversos , Fístula Pancreática/etiología , Fístula Pancreática/epidemiología , Adulto , Bilirrubina/sangre , Analgésicos Opioides/administración & dosificaciónRESUMEN
BACKGROUND: Hand-sewn anastomosis and stapled anastomosis are the 2 main types of gastrojejunal anastomotic methods in pancreaticoduodenectomy. There is ongoing debate regarding the most effective anastomotic method for reducing delayed gastric emptying after pancreaticoduodenectomy. This study aims to identify factors that influence delayed gastric emptying after pancreaticoduodenectomy and assess the impact of different anastomotic methods on delayed gastric emptying. METHODS: The study included 1,077 patients who had undergone either hand-sewn anastomosis (n = 734) or stapled anastomosis (n = 343) during pancreaticoduodenectomy between December 2016 and November 2021 at our department. We retrospectively analyzed the clinical data, and a 1:1 propensity score matching was performed to balance confounding variables. RESULTS: After propensity score matching, 320 patients were included in each group. Compared with the stapled anastomosis group, the hand-sewn anastomosis group had a significantly lower incidence of delayed gastric emptying (28 [8.8%] vs 55 [17.2%], P = .001) and upper gastrointestinal tract bleeding (6 [1.9%] vs 17 [5.3%], P = .02). Additionally, the hand-sewn anastomosis group had a significantly reduced postoperative length of stay and lower hospitalization expenses. However, the hand-sewn anastomosis group had a significantly longer operative time, which was consistent with the analysis before propensity score matching. Logistic regression analysis showed that stapled anastomosis, intra-abdominal infection, and clinically relevant postoperative pancreatic fistula were independent prognostic factors for delayed gastric emptying. CONCLUSION: Hand-sewn anastomosis was associated with a lower incidence rate of clinically relevant delayed gastric emptying after pancreaticoduodenectomy. Stapled anastomosis, intra-abdominal infection, and clinically relevant postoperative pancreatic fistula could increase the incidence of postoperative clinically relevant delayed gastric emptying. Hand-sewn anastomosis should be considered by surgeons to reduce the occurrence of postoperative delayed gastric emptying and improve patient outcomes.
Asunto(s)
Gastroparesia , Infecciones Intraabdominales , Humanos , Pancreaticoduodenectomía/efectos adversos , Pancreaticoduodenectomía/métodos , Estudios Retrospectivos , Gastroparesia/epidemiología , Gastroparesia/etiología , Gastroparesia/prevención & control , Fístula Pancreática/epidemiología , Fístula Pancreática/etiología , Fístula Pancreática/prevención & control , Anastomosis Quirúrgica/efectos adversos , Anastomosis Quirúrgica/métodos , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/prevención & control , Infecciones Intraabdominales/complicaciones , Vaciamiento Gástrico , Resultado del TratamientoRESUMEN
BACKGROUND: This study aimed to examine the rate of delayed emptying and other 90-day postoperative complications after total, subtotal, and distal gastrectomies for gastric adenocarcinoma in a population-based setting. METHODS: This study included all patients who underwent total, subtotal, or distal gastrectomy for gastric cancer in Finland in 2005-2016, with follow-up until December 31, 2019. Logistic regression provided the odds ratios with 95% CIs of 90-day mortality. The results were adjusted for age, sex, year of surgery, comorbidities, pathologic stage, and neoadjuvant therapy. RESULTS: A total of 2058 patients underwent total (n = 1227), subtotal (n = 450), or distal (n = 381) gastrectomy. In the total, subtotal, and distal gastrectomy groups, the rates of 90-day delayed emptying were 1.7%, 1.3%, and 2.1% in the whole cohort and 1.6%, 1.8%, and 3.5% in the subgroup analysis of R0 resections, respectively. The resection type was not associated with the risk of delayed emptying. Subtotal gastrectomy was associated with a lower risk of major complications and reoperations, whereas distal gastrectomy was associated with a lower risk of anastomotic complications. CONCLUSION: The extent of resection did not affect delayed emptying, whereas fewer postoperative complications were observed after subtotal or distal gastrectomy than after total gastrectomy.
Asunto(s)
Adenocarcinoma , Gastrectomía , Complicaciones Posoperatorias , Neoplasias Gástricas , Humanos , Neoplasias Gástricas/cirugía , Neoplasias Gástricas/patología , Gastrectomía/efectos adversos , Gastrectomía/métodos , Femenino , Masculino , Persona de Mediana Edad , Anciano , Finlandia/epidemiología , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Adenocarcinoma/cirugía , Adenocarcinoma/patología , Reoperación/estadística & datos numéricos , Gastroparesia/etiología , Gastroparesia/epidemiología , Vaciamiento GástricoRESUMEN
BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are effective in diabetes and obesity, reducing hyperglycemia by increasing insulin release and delaying gastric emptying. However, they can cause gastroparesis, raising concerns about aspiration during procedures. Recent guidelines advise discontinuing GLP-1 RA before surgery to reduce the risk of pulmonary aspiration. AIM: To evaluate the effect of GLP-1 RAs on gastric residual contents during endoscopic procedures. METHODS: A retrospective chart review at BronxCare Health System, New York, from January 2019 to October 2023, assessed gastric residue and aspiration in GLP-1 RA patients undergoing endoscopic procedures. Two groups were compared based on dietary status before the procedure. Data included demographics, symptoms of gastroparesis, opiate use, hemoglobin A1c, GLP-1 agonist indication, endoscopic details, and aspiration occurrence. IBM SPSS was used for analysis, calculating means, standard deviations, and applying Pearson's chi-square and t-tests for associations, with P < 0.05 as being significant. RESULTS: During the study, 306 patients were included, with 41.2% on a clear liquid/low residue diet and 58.8% on a regular diet before endoscopy. Most patients (63.1%) were male, with a mean age of 60 ± 12 years. The majority (85.6%) were on GLP-1 RAs for diabetes, and 10.1% reported digestive symptoms before endoscopy. Among those on a clear liquid diet, 1.5% had residual food at endoscopy compared to 10% on a regular diet, which was statistically significant (P = 0.03). Out of 31 patients with digestive symptoms, 13% had residual food, all from the regular diet group (P = 0.130). No complications were reported during or after the procedures. CONCLUSION: The study reflects a significant rise in GLP-1 RA use for diabetes and obesity. A 24-hour liquid diet seems safe for endoscopic procedures without aspiration. Patients with upper gastrointestinal symptoms might have a higher residual food risk, though not statistically significant. Further research is needed to assess risks based on diabetes duration, gastroparesis, and GLP-1 RA dosing, aiming to minimize interruptions in therapy during procedures.
Asunto(s)
Gastroparesia , Receptor del Péptido 1 Similar al Glucagón , Humanos , Estudios Retrospectivos , Masculino , Femenino , Persona de Mediana Edad , Receptor del Péptido 1 Similar al Glucagón/agonistas , Anciano , Gastroparesia/prevención & control , Gastroparesia/etiología , Gastroparesia/epidemiología , Gastroparesia/tratamiento farmacológico , Vaciamiento Gástrico/efectos de los fármacos , Hipoglucemiantes/uso terapéutico , Hipoglucemiantes/administración & dosificación , Endoscopía Gastrointestinal/métodos , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Adulto , Agonistas Receptor de Péptidos Similares al GlucagónRESUMEN
En este artículo se comentan los trabajos sobre trastornos funcionales y motores digestivos presentados en el congreso de la American Association of Gastroenterology (Digestive Diseases Week) del año 2015 que nos han parecido de mayor interés. Se siguen buscando biomarcadores para el síndrome del intestino irritable y, en este sentido, se han presentado nuevos datos. Se presentó un estudio que confirma que el uso de los antidepresivos a dosis bajas tiene efecto antinociceptivo y que no modifican los aspectos psicológicos de los pacientes con dispepsia funcional. Una aportación que podría ser de aplicabilidad inmediata es el uso de acupuntura eléctrica transcutánea, que ha demostrado ser eficaz en el control de la náusea en pacientes con gastroparesia. Se siguen aportando datos de la importancia de la dieta en el intestino irritable, aunque parece que la eficacia de la dieta baja en FODMAP está perdiendo fuelle con el tiempo. Se han comunicado múltiples datos de la eficacia a largo plazo del tratamiento con rifaximina en pacientes con intestino irritable con diarrea. Además, entre otras aportaciones, y más como curiosidad, se presentó un estudio que valoraba el efecto de la histamina en la dieta en pacientes con síndrome del intestino irritable
This article discusses the most interesting studies on functional and motor gastrointestinal disorders presented at Digestive Diseases Week (DDW), 2015. Researchers are still seeking biomarkers for irritable bowel syndrome and have presented new data. One study confirmed that the use of low-dose antidepressants has an antinociceptive effect without altering the psychological features of patients with functional dyspepsia. A contribution that could have immediate application is the use of transcutaneous electroacupuncture, which has demonstrated effectiveness in controlling nausea in patients with gastroparesis. New data have come to light on the importance of diet in irritable bowel syndrome, although the effectiveness of a low-FODMAP diet seems to be losing momentum with time. Multiple data were presented on the long-term efficacy of rifaximin therapy in patients with irritable bowel syndrome and diarrhoea. In addition, among other contributions, and more as a curiosity, a study evaluated the effect of histamine in the diet of patients with irritable bowel syndrome
Asunto(s)
Humanos , Enfermedades Funcionales del Colon/epidemiología , Síndrome del Colon Irritable/epidemiología , Enfermedades Inflamatorias del Intestino/epidemiología , Estreñimiento/epidemiología , Congresos como Asunto , Gastroparesia/epidemiología , Motilidad GastrointestinalRESUMEN
No disponible
Asunto(s)
Humanos , Diabetes Mellitus Tipo 2/epidemiología , Reflujo Gastroesofágico/epidemiología , Gastroparesia/epidemiología , Pirosis/epidemiologíaRESUMEN
La esclerosis sistémica es una enfermedad del tejido conectivo caracterizada por inflamación y fibrosis de múltiples órganos (piel, aparato digestivo, pulmón, riñón y corazón). Después de la piel, el órgano más afectado, con una frecuencia del 75 al 90%, es el tracto gastrointestinal. La afectación del tracto gastrointestinal se manifiesta por la aparición de disfagia orofaríngea, disfagia esofágica, reflujo gastroesofágico, gastroparesia, seudoobstrucción, sobrecrecimiento bacteriano y malabsorción intestinal, estreñimiento, diarrea y/o incontinencia fecal. Estas afectaciones condicionan la ingesta alimentaria y la absorción intestinal y conducen a la aparición progresiva de deficiencias nutricionales. Alrededor de un 30% de los pacientes con esclerosis sistémica presentan un riesgo de malnutrición. En el 5-10%, los trastornos gastrointestinales son la principal causa de muerte. Las estrategias terapéuticas existentes en la actualidad son limitadas y están dirigidas a reducir la sintomatología clínica. El manejo multidisciplinar de dichos pacientes, que incluya la intervención nutricional, contribuye a mejorar la sintomatología gastrointestinal, además de evitar la malnutrición, la morbilidad y aumentar la calidad de vida (AU)
Systemic sclerosis is a connective tissue disease characterized by inflammation and fibrosis of multiple organs (skin, gastrointestinal tract, lung, kidney and heart). After the skin, the organ most affected with a frequency of 75 to 90%, the gastrointestinal tract is more often involved. Gastrointestinal tract involvement is manifested by the appearance of oropharyngeal dysphagia, esophageal dysphagia, gastroesophageal reflux, gastroparesis, pseudo-obstruction, bacterial overgrowth and intestinal malabsorption, constipation, diarrhea and/or fecal incontinence. These effects influence food intake and intestinal absorption leading to the gradual emergence of nutritional deficiencies. About 30% of patients with systemic sclerosis are at risk of malnutrition. In 5-10%, gastrointestinal disorders are the leading cause of death. Therapeutic strategies currently available are limited and aimed at reducing clinical symptoms. The multidisciplinary management of these patients, including nutritional intervention, helps improve gastrointestinal symptoms, and avoid malnutrition, morbidity and improve quality of life (AU)
Asunto(s)
Humanos , Masculino , Femenino , 52503/educación , Fenómenos Fisiológicos de la Nutrición/fisiología , Esclerodermia Sistémica/dietoterapia , Esclerodermia Sistémica/epidemiología , Desnutrición/complicaciones , Desnutrición/diagnóstico , Trastornos de Deglución/dietoterapia , Trastornos de Deglución/epidemiología , Reflujo Gastroesofágico/complicaciones , Reflujo Gastroesofágico/diagnóstico , Esclerodermia Sistémica/prevención & control , Esclerodermia Sistémica/fisiopatología , Tracto Gastrointestinal/metabolismo , Tracto Gastrointestinal/fisiología , Gastroparesia/dietoterapia , Gastroparesia/epidemiología , Tamizaje Masivo/métodos , Tamizaje Masivo/prevención & controlRESUMEN
La diabetes mellitus tipo 2 es una enfermedad con una elevada prevalencia en nuestro medio, y con un gran impacto socioeconómico por constituir un factor de riesgo cardiovascular. Además, la diabetes mellitus tipo 2 presenta complicaciones crónicas que redundan en una mayor morbimortalidad. En el ámbito hospitalario, es una enfermedad altamente prevalente, motivo de ingreso o que empeora la evolución de enfermedades concomitantes. Dentro de las complicaciones crónicas de la diabetes, distinguimos las complicaciones microvasculares y macrovasculares. En ambas, el estricto control glicémico puede disminuir el riesgo de presentarlas, y además en las complicaciones microvasculares puede disminuir el riesgo de progresión de las mismas. Para reducir el riesgo de evolución de las complicaciones macrovasculares es necesario un abordaje integral que incluya el control de la hiperglucemia, la dislipemia, la hipertensión y el tabaquismo. El abordaje dietético en la diabetes mellitus tipo 2 va dirigido a controlar la hiperglucemia, a disminuir la hiperglicemia y la hipertrigliceridemia postprandial, a mejorar el perfil lipídico y a controlar la hipertensión arterial. En las situaciones en las que el paciente diabético precisa nutrición enteral deben considerarse los mismos objetivos de control metabólico que en el paciente que sigue dieta oral. Por ello, se han desarrollado fórmulas de nutrición enteral que ayuden a mejorar el perfil metabó- lico de los pacientes diabéticos, modificando el contenido y la fuente de carbohidratos, lípidos y fibra. Los pacientes con nefropatía diabética se benefician de una dieta baja en proteínas para retrasar la evolución a insuficiencia renal terminal. Los pacientes que presentan gastroparesia o enteropatía diabética deben considerarse de forma individual, y el tratamiento nutricional debe plantearse conjuntamente con otros tratamientos que ayuden a sincronizar el tratamiento hipoglucemiante con la absorción de nutrientes (AU)
Type 2 diabetes mellitus is a high prevalent disease in our area, with a great socioeconomic impact for constituting an important cardiovascular risk factor. In addition, type 2 diabetes mellitus produce chronic complications that redound in a major morbidity and mortality. In the hospital area, it is a highly prevalent disease, that motivate the hospital income or that worsens the evolution of concomitant diseases. Considering the chronic complications of diabetes, we distinguish the microvascular and macrovascular complications. In both, the strict glycemic control can diminish the risk of develop them, and in addition in case of microvascular complications it can diminish the risk of progression of the same ones. To reduce the risk of progression of macrovascular complications is necessary an integral boarding that includes the control of the hyperglycemia, the dislipemia, the hypertension and the smoking habit. The dietetic treatment in type 2 diabetes mellitus is focused to control the hyperglycemia, to diminish the postprandial hyperglycemia and hipertriglyceridemia, to improve the lipid profile and to control hypertension. In the situations in which the diabetic patient needs enteral nutrition we must be considered the same aims of metabolic control that in the patient who are on oral diet. For these reason, enteral nutrition formula have been developed to improve the metabolic profile of the diabetic patients, modifying the content and the source of carbohydrates, lipids and fiber. The patients with diabetic nephropathy benefits from a low diet for delay the evolution to renal terminal insufficiency. The patients who present gastroparesis or diabetic enteropathy must be considered of individual form and the nutritional treatment must appear together with other treatments that help to synchronize the hypoglycemic treatment with the absorption of nutrients (AU)